Mani Akhtari
About
Mani Akhtari is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery.
According to data from OpenAlex, Mani Akhtari has authored 21 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Mani Akhtari's work include Lymphoma Diagnosis and Treatment (11 papers), Advanced Radiotherapy Techniques (4 papers) and Breast Cancer Treatment Studies (4 papers). Mani Akhtari is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Advanced Radiotherapy Techniques (4 papers) and Breast Cancer Treatment Studies (4 papers). Mani Akhtari collaborates with scholars based in United States, United Kingdom and Netherlands. Mani Akhtari's co-authors include Sandra Abramowicz, Carrie L. Welch, Marie Sanson, Sonia Tolani, Mi Wang, Laurent Yvan‐Charvet, Jan Albert Kuivenhoven, Andrew Murphy, Nora Bijl and Alan R. Tall and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Blood.
In The Last Decade
Mani Akhtari
19 papers receiving 604 citations
Peers
Mani Akhtari
Glenn R. Ehresmann United States
Hidekazu Kayano Japan
Yoshie Sanayama Japan
Fengchun Zhang China
Kim Zuidwijk Netherlands
Daniela Laimer Austria
Yang‐Gun Suh South Korea
Magdalena Chechlińska Poland
Birgit Kovacs United States
Giovanna Motta Italy
Citations per year, relative to Mani Akhtari Mani Akhtari (= 1×)
peers
Glenn R. Ehresmann
Countries citing papers authored by Mani Akhtari
Since
Specialization
Citations
This map shows the geographic impact of Mani Akhtari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mani Akhtari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mani Akhtari more than expected).
Fields of papers citing papers by Mani Akhtari
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mani Akhtari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mani Akhtari. The network helps show where Mani Akhtari may publish in the future.
Co-authorship network of co-authors of Mani Akhtari
This figure shows the co-authorship network connecting the top 25 collaborators of Mani Akhtari. A scholar is included among the top collaborators of Mani Akhtari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mani Akhtari. Mani Akhtari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Reddy, Jay P., Mike Hernández, Jillian R. Gunther, et al.. (2017). Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma. British Journal of Haematology. 180(4). 545–549.
2.
Milgrom, Sarah A., Chelsea C. Pinnix, Hubert H. Chuang, et al.. (2017). Early‐stage Hodgkin lymphoma outcomes after combined modality therapy according to the post‐chemotherapy 5‐point score: can residual pet‐positive disease be cured with radiotherapy alone?. British Journal of Haematology. 179(3). 488–496.
3.
Milgrom, Sarah A., Grace L. Smith, Chelsea C. Pinnix, et al.. (2016). Prognostic Significance of the Postchemotherapy Positron Emission Tomography (PET)/Computed Tomography in Early-Stage Hodgkin Lymphoma: Can PET-Positive Patients Be Cured With Radiation Alone?. International Journal of Radiation Oncology*Biology*Physics. 96(2). S167–S167.
4.
Yehia, Zeinab Abou, G. Mikhaeel, Grace L. Smith, et al.. (2016). Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?. International Journal of Radiation Oncology*Biology*Physics. 96(5). 951–958.
5.
Gunther, Jillian R., Michelle A. Fanale, Jay P. Reddy, et al.. (2016). Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation. International Journal of Radiation Oncology*Biology*Physics. 96(1). 110–118.
6.
Akhtari, Mani, Ramiro Pino, Gary D. Lewis, et al.. (2016). Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators. Journal of Contemporary Brachytherapy. 6(6). 497–504.
7.
Akhtari, Mani & Bin S. Teh. (2016). Accelerated partial breast irradiation: advances and controversies. Chinese Journal of Cancer. 35(1). 31–31.
8.
Akhtari, Mani, Eric Bernicker, & Bin S. Teh. (2016). Chemotherapy in non-small cell lung cancer: opportunities for advancement. Chinese Journal of Cancer. 35(1). 56–56.
9.
Milgrom, Sarah A., Wenli Dong, Mani Akhtari, et al.. (2016). Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. International Journal of Radiation Oncology*Biology*Physics. 97(2). 333–338.
10.
Fanale, Michelle A., Jay P. Reddy, Mani Akhtari, et al.. (2016). Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation. International Journal of Radiation Oncology*Biology*Physics. 96(2). S21–S22.
11.
Pinnix, Chelsea C., Zeinab Abou Yehia, Grace L. Smith, et al.. (2016). More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone. International Journal of Radiation Oncology*Biology*Physics. 96(2). E489–E490.
12.
Reddy, Jay P., Mani Akhtari, Grace L. Smith, et al.. (2015). Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease. Clinical Lymphoma Myeloma & Leukemia. 15(11). 664–670.e2.
13.
Akhtari, Mani, Jay P. Reddy, Chelsea C. Pinnix, et al.. (2015). Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leukemia & lymphoma. 57(1). 34–38.
14.
Youssef, Bassem, Jay P. Reddy, Chelsea C. Pinnix, et al.. (2015). Incidence and predictors of Lhermitte’s sign among patients receiving mediastinal radiation for lymphoma. Radiation Oncology. 10(1). 206–206.
15.
Akhtari, Mani, Ramiro Pino, Sarah B. Scarboro, et al.. (2015). Dosimetric considerations and early clinical experience of accelerated partial breast irradiation using multi-lumen applicators in the setting of breast augmentation. Journal of Contemporary Brachytherapy. 6(6). 423–429.
16.
Yehia, Zeinab Abou, G. Mikhaeel, Grace L. Smith, et al.. (2015). Radiation Pneumonitis Risk after Bleomycin Toxicity in Hodgkin Lymphoma Patients. Blood. 126(23). 1511–1511.
17.
Akhtari, Mani, Jorge R. Quesada, Mary R. Schwartz, Stephen Chiang, & Bin S. Teh. (2014). Sarcoidosis Presenting As Metastatic Lymphadenopathy in Breast Cancer. Clinical Breast Cancer. 14(5). e107–e110.
18.
Akhtari, Mani, P Nitsch, Barbara L. Bass, & Bin S. Teh. (2014). Long-term outcome of accelerated partial breast irradiation using a multilumen balloon applicator in a patient with existing breast implants. Brachytherapy. 14(2). 289–292.
19.
Murphy, Andrew, Mani Akhtari, Sonia Tolani, et al.. (2011). ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. Journal of Clinical Investigation. 121(10). 4138–4149.
20.
Murphy, Andrew, Tamara A. Pagler, Mani Akhtari, & Alan R. Tall. (2010). Abstract 19263: Enhancing Cholesterol Efflux Pathways Suppresses Hematopoietic Stem Cell Proliferation and Monocytosis in apoE−/− Mice. Circulation. 122.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Glenn R. Ehresmann Breakdown of academic impact, for papers by Hidekazu Kayano Breakdown of academic impact, for papers by Yoshie Sanayama Breakdown of academic impact, for papers by Fengchun Zhang Breakdown of academic impact, for papers by Kim Zuidwijk Breakdown of academic impact, for papers by Daniela Laimer Breakdown of academic impact, for papers by Yang‐Gun Suh Breakdown of academic impact, for papers by Magdalena Chechlińska Breakdown of academic impact, for papers by Birgit Kovacs Breakdown of academic impact, for papers by Giovanna Motta